Nestlé to sell-off Mexican Pfizer infant formula business in anti-trust deal
Mexican anti-trust officials have approved Nestlé’s $11.85bn (€9bn) acquisition of Pfizer Nutrition on the condition that the Swiss firm sells off the acquired infant formula business to an independent third party.